Sarepta Therapeutics

Stock exchange concept
Biotech

Sarepta sells 9M Arrowhead shares for $174M cash

Sarepta sold 9.2 million shares of Arrowhead common stock that are expected to equate to at least $174 million.
Gabrielle Masson Aug 13, 2025 5:44pm
FDA
Favicon Fierce Pharma

Vinay Prasad is back at the FDA after last month's surprise ouster

Aug 9, 2025 12:22pm
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
FDA
Favicon Fierce Pharma

Vinay Prasad departs FDA amid controversy over gene therapy

Jul 30, 2025 9:33am
sarepta building
Favicon Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

Jul 28, 2025 6:02pm
timer sand clocks time

Arrowhead meets $100M milestone, awaits Sarepta payment

Jul 28, 2025 3:10pm